Mirum Pharmaceuticals Inc. has agreed to acquire Bluejay Therapeutics, a privately held biotechnology company focused on ...

As 2026 approaches, the clinical research and development landscape is evolving beyond traditional scientific innovation with ...

Natera Inc., a cell-free DNA and precision medicine company, has acquired Foresight Diagnostics, a leader in ultrasensitive ...

The FDA has approved BMS’ Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed CAR T cell therapy, for adults with ...

Jubilant Therapeutics Inc., a clinical-stage biopharmaceutical company, has appointed Daniel J. O'Connor as President & Chief ...

Senior VP of Business Development shares insight on industry and packaging trends.

Quotient Sciences and Intrepid Labs have announced a multi-year strategic partnership to advance the use of artificial ...

Trevi Therapeutics Inc., a clinical-stage biopharmaceutical company, has named David Hastings as Chief Financial Officer.

Neurimmune has expanded its transthyretin amyloid cardiomyopathy (ATTR-CM) collaboration with Alexion, an AstraZeneca company ...

Aphena Pharma Solutions is a full range packaging and manufacturing service provider in the pharmaceutical (OTC, Rx), medical device, and biologics industries. With our continued investment in ...

Rentschler Biopharma, a global CDMO, and Coriolis Pharma, a global contract research and development organization, have ...

System features “card-to-card” technology with cardboard blister and backing comprised of the same material.